Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
Tan MH, Wong CF, Tan HL, Yang XJ, Ditlev J, Matsuda D, Khoo SK, Sugimura J, Fujioka T, Furge KA, Kort E, Giraud S, Ferlicot S, Vielh P, Amsellem-Ouazana D, Debré B, Flam T, Thiounn N, Zerbib M, Benoît G, Droupy S, Molinié V, Vieillefond A, Tan PH, Richard S, Teh BT. Tan MH, et al. Among authors: fujioka t. BMC Cancer. 2010 May 12;10:196. doi: 10.1186/1471-2407-10-196. BMC Cancer. 2010. PMID: 20462447 Free PMC article.
Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
Konda R, Sugimura J, Sohma F, Katagiri T, Nakamura Y, Fujioka T. Konda R, et al. Among authors: fujioka t. J Urol. 2008 Aug;180(2):481-5. doi: 10.1016/j.juro.2008.04.006. Epub 2008 Jun 11. J Urol. 2008. PMID: 18550099
Telomerase activity in human renal cell carcinoma.
Fujioka T, Hasegawa M, Suzuki Y, Suzuki T, Sugimura J, Tanji S, Koike H. Fujioka T, et al. Int J Urol. 2000 Jan;7(1):16-21. doi: 10.1046/j.1442-2042.2000.00130.x. Int J Urol. 2000. PMID: 10701886 Free article.
Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan.
Eto M, Kawano Y, Hirao Y, Mita K, Arai Y, Tsukamoto T, Hashine K, Matsubara A, Fujioka T, Kimura G, Shinohara N, Tatsugami K, Hinotsu S, Naito S; Japan RCC Trialist Collaborative Group (JRTCG) investigators. Eto M, et al. Among authors: fujioka t. BMC Cancer. 2015 Oct 9;15:667. doi: 10.1186/s12885-015-1675-1. BMC Cancer. 2015. PMID: 26452347 Free PMC article. Clinical Trial.
1,259 results